TCIM
ALNA

TIAA CREF Investment Management’s Allena Pharmaceuticals ALNA Stock Holding History

TIAA CREF Investment Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$114K Sell
16,211
-45
-0.3% -$326 ﹤0.01% 2949
2018
Q4 		$89K Hold
16,256
– – ﹤0.01% 2969
2018
Q3 		$175K Sell
16,256
-937
-5% -$10.3K ﹤0.01% 3007
2018
Q2 		$224K Buy
17,193
+2,515
+17% +$36.3K ﹤0.01% 3016
2018
Q1 		$162K Buy
14,678
+7,065
+93% +$59K ﹤0.01% 2991
2017
Q4 		$77K Buy
+7,613
New +$93.8K ﹤0.01% 3052

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TIAA CREF Investment Management's ALNA Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Allena Pharmaceuticals (ALNA) stake by 0.28% in Q1 2019, selling an estimated $326 and leaving 16,211 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

TIAA CREF Investment Management first reported a position in ALNA in Q4 2017 and has held it in 6 quarters since. The position peaked at $224K in Q2 2018. 49 funds tracked by Wall St. Rank hold ALNA as of Q1 2019.

  • TIAA CREF Investment Management held 16,211 shares of Allena Pharmaceuticals worth $114K as of Q1 2019.
  • TIAA CREF Investment Management sold 45 Allena Pharmaceuticals shares in Q1 2019, an estimated $326.
  • Allena Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2949 holding.
  • TIAA CREF Investment Management first reported a position in Allena Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
  • TIAA CREF Investment Management's Allena Pharmaceuticals position peaked at $224K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.